• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过放射免疫测定法测定的芬太尼药代动力学。

Pharmacokinetics of fentanyl as determined by radioimmunoassay.

作者信息

Schleimer R, Benjamini E, Eisele J, Henderson G

出版信息

Clin Pharmacol Ther. 1978 Feb;23(2):188-94. doi: 10.1002/cpt1978232188.

DOI:10.1002/cpt1978232188
PMID:620479
Abstract

The pharmacokinetics of fentanyl were determined in human surgical patients using radioimmunoassay. Fentanyl was measured in the serum, cerebrospinal fluid (CSF), and urine of patients receiving 0.1, 0.5, or 1.0 mg/m2 of fentanyl intravenously. The kinetics of the disappearance of fentanyl from the serum were very similar at the three administered doses. At all doses, levels fell rapidly in the first five minutes to approximately 20% of the peak value. Thereafter, serum levels fell more slowly with an observed half-life (t 1/2) of approximately 10 to 20 min. depending on dose. By 2 hr serum levels had stabilized at low values (1, 5, and 8 ng/ml) and continued to decrease very slowly thereafter, with an observed t 1/2 of 1 to 2 hr at the low dose (0.1 mg/m2) and greater than 4 hr at 0.5 and 1.0 mg/m2. The serum elimination curves were dissected and described mathematically in terms of a three-compartment model. Urinary excretion of fentanyl accounted for 15% to 20% of the administered dose. Urinary excretion was very low during the first 2 hr, suggesting that this route of elimination is not important in terminating the actions of fentanyl in man. Fentanyl levels in the CSF of patients given terminating the actions of fentanyl in man. Fentanyl levels in the CSF of patients given the high dose (1 mg/m2) were low, and never exceeded 4 ng/ml. Peak levels of fentanyl in the CSF were not seen until at least 15 min after administration.

摘要

采用放射免疫分析法测定了芬太尼在接受外科手术的患者体内的药代动力学。对静脉注射0.1、0.5或1.0mg/m²芬太尼的患者的血清、脑脊液(CSF)和尿液进行了芬太尼测定。在这三种给药剂量下,芬太尼从血清中消失的动力学非常相似。在所有剂量下,血药浓度在前5分钟迅速下降至峰值的约20%。此后,血清水平下降得更慢,观察到的半衰期(t 1/2)约为10至20分钟,具体取决于剂量。到2小时时,血清水平已稳定在低值(1、5和8ng/ml),此后继续非常缓慢地下降,低剂量(0.1mg/m²)时观察到的t 1/2为1至2小时,0.5和1.0mg/m²时大于4小时。血清消除曲线根据三室模型进行剖析并进行数学描述。芬太尼的尿排泄量占给药剂量的15%至20%。在最初2小时内尿排泄量非常低,这表明该消除途径在终止芬太尼在人体内的作用方面并不重要。给予高剂量(1mg/m²)的患者脑脊液中的芬太尼水平较低,从未超过4ng/ml。脑脊液中芬太尼的峰值水平直到给药后至少15分钟才出现。

相似文献

1
Pharmacokinetics of fentanyl as determined by radioimmunoassay.通过放射免疫测定法测定的芬太尼药代动力学。
Clin Pharmacol Ther. 1978 Feb;23(2):188-94. doi: 10.1002/cpt1978232188.
2
Pharmacokinetics of fentanyl in neonates.芬太尼在新生儿中的药代动力学。
Anesth Analg. 1986 Mar;65(3):227-32.
3
Intravenous fentanyl kinetics.静脉注射芬太尼的动力学
Clin Pharmacol Ther. 1980 Jul;28(1):106-14. doi: 10.1038/clpt.1980.138.
4
Dose-independent pharmacokinetics of fentanyl.芬太尼的非剂量依赖性药代动力学。
Anesthesiology. 1983 Dec;59(6):537-40. doi: 10.1097/00000542-198312000-00009.
5
Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery.大剂量芬太尼的药代动力学。一项针对心脏手术患者的研究。
Br J Anaesth. 1980 Aug;52(8):795-801. doi: 10.1093/bja/52.8.795.
6
Bleomycin clinical pharmacology by radioimmunoassay.通过放射免疫测定法研究博来霉素的临床药理学。
Cancer Chemother Pharmacol. 1982;9(1):22-5. doi: 10.1007/BF00296756.
7
Pharmacokinetics of alfentanil in man.阿芬太尼在人体中的药代动力学。
Anesth Analg. 1982 Aug;61(8):657-61.
8
Age and fentanyl pharmacokinetics.
Anesth Analg. 1982 Dec;61(12):968-71.
9
Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery.
Anesthesiology. 1986 Mar;64(3):334-8. doi: 10.1097/00000542-198603000-00006.
10
Fentanyl pharmacokinetics in awake volunteers.清醒志愿者体内芬太尼的药代动力学
J Clin Pharmacol. 1980 Nov-Dec;20(11):652-8. doi: 10.1002/j.1552-4604.1980.tb01682.x.

引用本文的文献

1
Comparison of fentanyl-induced brain oxygen responses following intravenous and intraperitoneal injections in rats.大鼠静脉注射和腹腔注射芬太尼后脑氧反应的比较。
Neuropharmacology. 2025 Jun 15;271:110412. doi: 10.1016/j.neuropharm.2025.110412. Epub 2025 Mar 12.
2
Hypoxic effects of heroin and fentanyl and their basic physiological mechanisms.海洛因和芬太尼的缺氧效应及其基本生理机制。
Am J Physiol Lung Cell Mol Physiol. 2024 Dec 1;327(6):L930-L948. doi: 10.1152/ajplung.00251.2024. Epub 2024 Oct 15.
3
Oxygen fluctuations in the brain and periphery induced by intravenous fentanyl: effects of dose and drug experience.
静脉注射芬太尼诱导的脑和外周的氧波动:剂量和药物经验的影响。
J Neurophysiol. 2024 Aug 1;132(2):322-334. doi: 10.1152/jn.00177.2024. Epub 2024 Jun 12.
4
Brain oxygen responses induced by opioids: focus on heroin, fentanyl, and their adulterants.阿片类药物引起的脑氧反应:聚焦于海洛因、芬太尼及其掺杂物。
Front Psychiatry. 2024 Jan 17;15:1354722. doi: 10.3389/fpsyt.2024.1354722. eCollection 2024.
5
Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level.在定量系统药理学模型中增加纳洛酮剂量,该模型预测阿片μ受体水平上纳洛酮-芬太尼的竞争。
PLoS One. 2020 Jun 16;15(6):e0234683. doi: 10.1371/journal.pone.0234683. eCollection 2020.
6
Correction to: Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.《芬太尼及其衍生物在儿童中的药代动力学:综述》勘误
Clin Pharmacokinet. 2018 Mar;57(3):393-417. doi: 10.1007/s40262-017-0609-2.
7
Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.芬太尼及其衍生物在儿童中的药代动力学:全面综述。
Clin Pharmacokinet. 2018 Feb;57(2):125-149. doi: 10.1007/s40262-017-0569-6.
8
Intravenous hypnotic regimens in patients with liver disease; a review article.肝病患者的静脉催眠方案;一篇综述文章。
Anesth Pain Med. 2015 Feb 24;5(1):e23923. doi: 10.5812/aapm.23923. eCollection 2015 Feb.
9
Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.甲氧基羰基依托咪酯:一种新型的快速代谢且超短效的依托咪酯类似物,不会产生长期的肾上腺皮质抑制。
Anesthesiology. 2009 Aug;111(2):240-9. doi: 10.1097/ALN.0b013e3181ae63d1.
10
Pharmacodynamics of fentanyl citrate in patients undergoing aortocoronary bypass.枸橼酸芬太尼在接受主动脉冠状动脉旁路移植术患者中的药效学
Cardiovasc Dis. 1981 Sep;8(3):405-412.